Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCombined Modality TherapyTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousCyclophosphamideMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsStem Cell TransplantationLymphoma, Non-HodgkinBlood Component RemovalTreatment OutcomeMultiple MyelomaGraft vs Host DiseaseMyeloablative AgonistsStem CellsHematopoietic Stem CellsBusulfanGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionSalvage TherapyLymphomaRecurrenceCarmustineCytophagocytosisCord Blood Stem Cell TransplantationIfosfamideAntineoplastic AgentsVincristineHodgkin DiseaseLymphoma, T-CellDisease-Free SurvivalHematopoiesisCytarabineAmyloidosisTransplantation ChimeraNeoplasmsSurvival RateRetrospective StudiesTissue DonorsSurvival AnalysisDoxorubicinTime FactorsWhole-Body IrradiationHistocompatibility TestingHistocompatibilityInfectionPlatelet CountBlood Cell CountCarboplatinPrednisoneTransplantation, IsogeneicPOEMS SyndromeLeukemia, Myeloid, AcuteLeukemiaImmunosuppressive AgentsFollow-Up StudiesDexamethasoneVidarabineRecombinant ProteinsProspective StudiesBone Marrow PurgingFatal OutcomeBlood CellsEmbryonic Stem CellsFeasibility StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectImmunophenotypingMyelodysplastic SyndromesAdult Stem CellsLymphoma, B-CellMesenchymal Stem Cell TransplantationPrognosisHematologic DiseasesLymphocyte DepletionChemotherapy, AdjuvantLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticT-LymphocytesBreast NeoplasmsBone MarrowBlood Transfusion, AutologousFlow CytometryHLA AntigensLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaCell SeparationBlood DonorsLeukocytes, Mononuclear